SCOPUS 정보 검색 플랫폼

Movement Disorders

Volumn 15, Issue 6, 2000, Pages 1230-1237

Risperidone in the treatment of dopamine-induced psychosis in Parkinson's disease: An open pilot trial

(4) Mohr, Erich a,b Mendis, Tilak c Hildebrand, Kathleen a,b De Deyn, Peter Paul d

a PRA International USA (Netherlands)

b UNIVERSITY OF OTTAWA (Canada)

c UNIVERSITY OF OTTAWA (Canada)

d UNIVERSITY OF ANTWERP (Belgium)

Author keywords

Extrapyramidal symptoms; Parkinson's disease; Psychosis; Risperidone

Indexed keywords

ANTIPARKINSON AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OLANZAPINE; ONDANSETRON; PLACEBO; QUETIAPINE; RISPERIDONE; SEROTONIN 3 AGONIST;

ADULT; AGED; AGRANULOCYTOSIS; ANXIETY NEUROSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DELUSION; DISEASE SEVERITY; DOSE RESPONSE; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GAIT DISORDER; HALLUCINATION; HUMAN; HYPOKINESIA; LEUKOPENIA; MAINTENANCE THERAPY; MALE; PARKINSONISM; PILOT STUDY; PRIORITY JOURNAL; PSYCHOSIS; SYMPTOM; THROMBOCYTOPENIA;

ADULT; AGED; AGED, 80 AND OVER; ANTIPARKINSON AGENTS; ANTIPSYCHOTIC AGENTS; BELGIUM; CANADA; DOPAMINE; DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOSES, SUBSTANCE-INDUCED; RISPERIDONE; TREATMENT OUTCOME;

EID: 0033709683 PISSN: 08853185 EISSN: None Source Type: Journal
DOI: 10.1002/1531-8257(200011)15:6<1230::AID-MDS1026>3.0.CO;2-9 Document Type: Article

Times cited : (81)

References (50)

1
- 0031459717
- Parkinson's disease
- (1997) Psychiatr Clin North Am , vol.20 , pp. 769-790
- Barbosa, E.R.¹ Limongi, J.C.P.² Cummings, J.L.³

2
- 0030989569
- Parkinson's disease: Prospects for improved drug therapy
- (1997) Trends Pharmacol Sci , vol.18 , pp. 156-163
- Hagan, J.J.¹ Middlemiss, D.N.² Sharpe, P.C.³ Poste, G.H.⁴

3
- 0028240629
- Parkinson's disease
- (1994) J Neurol Neurosurg Psychiatry , vol.57 , pp. 672-681
- Marsden, C.D.¹

4
- 0030986876
- Parkinson's disease
- (1997) Postgrad Med J , vol.73 , pp. 257-264
- Playfer, J.R.¹

5
- 0024323601
- Visual hallucinations in the elderly associated with the use of levodopa
- (1989) Postgrad Med J , vol.65 , pp. 358-361
- Banjeree, A.K.¹ Falkai, P.G.² Savidge, M.³

6
- 0019121320
- Drug holiday and management of Parkinson's disease
- (1980) Neurology , vol.30 , pp. 1257-1261
- Weiner, W.J.¹ Koller, W.C.² Perlik, S.T.³ Nausieda, P.A.⁴ Klawans, H.L.⁵

7
- 0015132846
- Psychiatric aspects in parkinsonism treated with L-dopa
- (1971) J Neurol Neurosurg Psychiatry , vol.34 , pp. 502-507
- Damasio, A.R.¹ Antunes, J.L.² Macedo, C.³

8
- 0025073398
- Dopaminergic psychosis in advanced Parkinson's disease
- (1990) Adv Neurol , vol.53 , pp. 391-397
- Fischer, P.¹ Danielczyk, W.² Simanyi, M.³ Streifler, M.B.⁴

9
- 0026466318
- Optimization of levodopa therapy
- 39-43
- (1992) Neurology , vol.42 , Issue.SUPPL. 1 , pp. 57-60
- Pfeiffer, R.¹

10
- 0030983603
- Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment
- (1997) Drugs Aging , vol.10 , pp. 367-383
- Young, B.K.¹ Camicioli, R.² Ganzini, L.³

11
- 0028213564
- Clozapine: A 2-year open trial in Parkinson's disease patients with psychosis
- (1994) Neurology , vol.44 , pp. 544-546
- Factor, S.A.¹ Brown, D.² Molho, E.S.³ Podskalny, G.D.⁴

12
- 0024418579
- Clozapine in the treatment of psychosis in Parkinson's disease
- (1989) Neurology , vol.39 , pp. 1219-1221
- Friedman, J.H.¹ Lannon, M.C.²

13
- 0031919315
- Clozapine use in Parkinson's disease: A retrospective analysis of a large multicentered clinical experience
- (1998) Mov Disord , vol.13 , pp. 377-382
- Trosch, R.M.¹ Friedman, J.H.² Lannon, M.C.³

14
- 0024426112
- Clozapine neuroleptic-induced EPS and tardive dyskinesia
- (1989) Psychopharmacology , vol.99
- Casey, D.E.¹

15
- 0023812652
- Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine
- (1988) Arch Gen Psychiatry , vol.45 , pp. 789-796
- Kane, J.¹ Honigfeld, G.² Singer, J.³ Meltzer, H.⁴

16
- 0028356138
- Risperidone for hallucinations in levodopa-treated Parkinson's disease patients
- [Letter]
- (1994) Lancet , vol.343 , pp. 1370-1371
- Meco, G.¹ Alessandri, A.² Bonifati, V.³ Giustini, P.⁴

17
- 0028325269
- Symptomatic relief from treatment-induced psychosis in Parkinson's disease: An open-label pilot study with remoxipride
- (1994) Mov Disord , vol.9 , pp. 197-200
- Mendis, T.¹ Mohr, E.² George, A.³ Rusk, I.N.⁴ Gray, P.⁵ Grimes, J.D.⁶

18
- 0027958705
- Risperidone
- (1994) Lancet , vol.343 , pp. 457-460
- Livingston, M.G.¹

19
- 0026741578
- Risperidone: Clinical safety and efficacy in schizophrenia
- (1992) Psychopharmacol Bull , vol.28 , pp. 213-218
- Borison, R.L.¹ Pathiraja, A.P.² Diamond, B.I.³ Meibach, R.C.⁴

20
- 0027475985
- A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients
- (1993) J Clin Psychopharmacol , vol.13 , pp. 25-40
- Chouinard, G.¹ Jones, B.² Remington, G.³

21
- 0026550602
- Risperidone versus haloperidol in the treatment of chronic schizophrenic inpatients; a multicentre, double-blind comparative study
- (1992) Acta Psychiatr Scand , vol.85 , pp. 295-305
- Claus, A.¹ Bollen, J.² De Cuyper, H.³

22
- 0007002461
- Risperidone in the treatment of chronic schizophrenic patients: An international multicentre double-blind, parallel group comparative study versus haloperidol
- Internal Clinical Research Report. Janssen Research Foundation. November 1
- Peuskens, J.¹ Heylen, S.²

23
- 0025024587
- Combined serotonin 5-HT2 and dopamine-D2 antagonism in schizophrenia: Clinical, extrapyramidal and neuroendocrine response in a preliminary trial with risperidone (R64 766)
- (1990) Human Psychopharmacology , vol.5 , pp. 225-231
- Bersani, G.¹ Bressa, G.M.² Meco, G.³ Marini, S.⁴ Pozzi, F.⁵

24
- 0024474379
- The efficacy of the D2 and 5HT antagonist risperidone in the treatment of chronic psychosis: An open dose-finding trial
- (1989) Schizophr Res , vol.2 , pp. 411-415
- Castelao, J.F.¹ Ferreira, L.² Gelders, Y.G.³ Heylen, S.L.⁴

25
- 0025094689
- Pilot clinical investigation of risperidone in the treatment of psychotic subjects
- (1990) Pharmacopsychiatry , vol.23 , pp. 206-211
- Gelders, Y.G.¹ Heylen, S.L.E.² Vanden Bussche, G.³ Reyntjens, A.J.⁴ Janssen, P.A.⁵

26
- 0024385168
- Risperidone in the treatment of chronic schizophrenia with tardive dyskinesia: A single-blind cross-over trial versus placebo
- (1989) Curr Ther Res , vol.46 , pp. 876-883
- Meco, G.¹ Bedini, L.² Bonifati, V.³ Sonsini, U.⁴

27
- 0024166351
- Risperidone (R64 766) in psychotic subjects: A first clinical therapeutic exploration
- (1988) Acta Psychiatr Belg , vol.88 , pp. 233-241
- Roose, K.¹ Gelders, Y.² Heylemn, S.³

28
- 0027146306
- Risperidone versus perphenazine in the treatment of chronic schizophrenic patients with acute exacerbations
- (1993) Acta Psychiatr Scand , vol.88 , pp. 395-402
- Hoyberg, O.J.¹ Fensbo, C.² Remvig, J.³ Lingjaerde, O.⁴ Sloth-Nielson, M.⁵ Salvesen, I.⁶

29
- 0028342655
- Risperidone in the treatment of schizophrenia
- (1994) Am J Psychiatry , vol.151 , pp. 825-835
- Marder, S.R.¹ Meibach, R.C.²

30
- 0028865612
- Risperidone in the treatment of patients with chronic schizophrenia: A multi-national, multi-centre, double-blind, parallel-group study versus haloperidol
- Risperidone Study Group. discussion 727-733.
- (1995) Br J Psychiatry , vol.166 , pp. 712-726
- Peuskens, J.¹

31
- 0030067199
- Antipsychotic and anxiolytic properties of risperidone, haloperidol and methotrimeprazine in schizophrenic patients
- (1996) J Clin Psychopharmacol , vol.16 , pp. 38-44
- Blin, O.¹ Azorin, J.M.² Bouhours, P.³

32
- 0028921092
- Risperidone versus zuclopenthixol in the treatment of acute schizophrenic episodes: A double-blind parallel-group trial
- (1995) Acta Psychiatr Scand , vol.91 , pp. 271-277
- Huttunen, M.O.¹ Piepponen, T.² Rantanen, H.³ Larmo, I.⁴ Nyholm, R.⁵ Raitasuo, V.⁶

33
- 0031936203
- Risperidone in the treatment of psychosis in Parkinson's disease
- (1998) Annales de Psychiatrie , vol.13 , pp. 41-47
- Anguenot, A.¹ Gil, R.² Senon, J.L.³ Couderq, C.⁴ Neau, J.P.⁵

34
- 0031971141
- Risperidone in levodopa induced dyskineseae
- (1998) J Neurol. Neurosurg Psychiatry , vol.64 , pp. 135-142
- Meco, G.¹ Fabrizio, E.² Alessandri, A.³ Vanacore, N.⁴ Bonifati, V.⁵

35
- 0030814528
- Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study
- (1997) Mov Disord , vol.12 , pp. 610-612
- Meco, G.¹ Alessandri, A.² Giustini, P.³ Bonifati, V.⁴

36
- 0031457966
- The use of risperidone for psychosis and agitation in demented patients with Parkinson's disease
- (1997) J Neuropsychiatry Clin Neurosci , vol.9 , pp. 594-597
- Workman R.H., Jr.¹ Orengo, C.A.² Bakey, A.A.³ Molinari, V.A.⁴ Kunik, M.E.⁵

37
- 0007001109
- Risperidone for treatment of psychosis in patients with Parkinson's disease
- 8th Congress of the International Psychogeriatric Association; August 17-22, Jerusalem, Israel
- (1997) , pp. 63
- Yuvarajan, R.¹

38
- 9044224024
- Drug-induced psychosis in Parkinson's disease: A review of management
- (1996) CNS Drugs , vol.5 , pp. 166-174
- Mendis, T.¹ Barclay, C.L.² Mohr, E.³

39
- 0023606101
- The Positive and Negative Syndrome Scale (PANSS) for schizophrenia
- (1987) Schizophr Bull , vol.13 , pp. 261-276
- Kay, S.R.¹ Fiszbein, A.² Opler, L.A.³

40
- 0007098475
- ECDEU Assessment Manual for Psychopharmacology, revised. DHEW Publication No. (ADM) Rockville, MD: National Institute of Mental Health
- (1976) , pp. 76-338
- Guy, W.¹

41
- 0000224448
- And members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds, Recent Developments in Parkinson's Disease, Florham Park, NJ: Macmillan Care Information
- (1987) , vol.2 , pp. 153-164
- Fahn, S.¹ Elton, R.L.²

42
- 0029203028
- Parkinson's disease: Drug-induced psychiatric states
- (1995) Adv Neurol , vol.65 , pp. 115-138
- Factor, S.A.¹ Molho, E.S.² Podskalny, G.D.³ Brown, D.⁴

43
- 0027343947
- Treatment of drug-induced psychosis in Parkinson's disease with clozapine
- (1993) Adv Neurol , vol.60 , pp. 703-706
- Greene, P.¹ Cote, L.² Fahn, S.³

44
- 0028144914
- Risperidone in Parkinson's disease
- [Letter]
- (1994) Lancet , vol.344 , pp. 681
- Ford, B.¹ Lynch, T.² Greene, P.³

45
- 0029610790
- Risperidone versus clozapine in the treatment of psychosis in six patients with Parkinson's disease and other akinetic-rigid syndromes
- (1995) J Clin Psychiatry , vol.56 , pp. 556-559
- Rich, S.S.¹ Friedman, J.H.² Ott, B.R.³

46
- 0031746779
- Quetiapine (Seroquel) in the treatment of psychosis in patients with PD
- (1998) J Neuropsychiatry Clin Neurosci , vol.10 , pp. 216-219
- Pars, M.A.¹ Bastani, B.²

47
- 0029161630
- Psychosis in advanced Parkinson's disease: Treatment with Ondansetron, a 5HT3 receptor agonist
- (1995) Neurology , vol.45 , pp. 1305-1308
- Zoldan, J.¹ Friedberg, G.² Livneh, M.³ Melamed, E.⁴

48
- 0027398865
- Ondansetron for hallucinosis in advanced Parkinson's disease
- (1993) Lancet , vol.341 , pp. 562-563
- Zoldan, J.¹ Friedberg, G.² Goldberg-Stern, H.³ Melamed, E.⁴

49
- 0032942169
- Management of Parkinson's disease: A review of current and new therapies
- (1999) Can J Neurol Sci , vol.26 , pp. 89-103
- Mendis, T.¹ Suchowersky, O.² Lang, A.³ Gauthier, S.⁴

50
- 0033541028
- Neurologic side effects in neurolepticnaive patients treated with haloperidol or risperidone
- (1999) Neurology , vol.52 , pp. 782-785
- Rosebush, P.I.¹ Mazurek, M.F.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.